We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.99B
AUM Growth
-$31M
Cap. Flow
+$2.59M
Cap. Flow %
0.13%
Top 10 Hldgs %
17.9%
Holding
309
New
25
Increased
122
Reduced
118
Closed
40

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$22.7M
2
PFE icon
Pfizer
PFE
+$21.5M
3
DGX icon
Quest Diagnostics
DGX
+$16.8M
4
MOS icon
The Mosaic Company
MOS
+$15.1M
5
HWC icon
Hancock Whitney
HWC
+$13.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$16M
2
MRK icon
Merck
MRK
+$15.9M
3
LYB icon
LyondellBasell Industries
LYB
+$15.7M
4
PSX icon
Phillips 66
PSX
+$13.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$11.1M

Sector Composition

Rank Sector Weight
1 Financials 24.91%
2 Industrials 16.38%
3 Technology 11.11%
4 Healthcare 10.84%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGS icon
276
B&G Foods
BGS
$285M
– –
-245,235
Closed -$2.18M
BRY
277
DELISTED
Berry Corp
BRY
– –
-756,064
Closed -$3.89M
CHRD icon
278
Chord Energy
CHRD
$7.79B
– –
-52,009
Closed -$6.77M
CRI icon
279
Carter's
CRI
$1.43B
– –
-4,288
Closed -$279K
CSGS
280
DELISTED
CSG Systems International
CSGS
– –
-82,790
Closed -$4.03M
EHC icon
281
Encompass Health
EHC
$11.2B
– –
-4,050
Closed -$391K
ETR icon
282
Entergy
ETR
$54.1B
– –
-10,794
Closed -$710K
EW icon
283
Edwards Lifesciences
EW
$47.6B
– –
-3,325
Closed -$219K
GES
284
DELISTED
Guess Inc
GES
– –
-266,779
Closed -$5.37M
GMS
285
DELISTED
GMS Inc
GMS
– –
-3,964
Closed -$359K
GSK icon
286
GSK
GSK
$103B
– –
-392,496
Closed -$16M
HDSN
287
Hudson Technologies
HDSN
$267M
– –
-548,330
Closed -$4.57M
HII icon
288
Huntington Ingalls Industries
HII
$11.3B
– –
-1,511
Closed -$399K
JBI icon
289
Janus International
JBI
$722M
– –
-25,685
Closed -$260K
LYB icon
290
LyondellBasell Industries
LYB
$19.5B
– –
-163,204
Closed -$15.7M
MBIN icon
291
Merchants Bancorp
MBIN
$2.19B
– –
-77,329
Closed -$3.48M
MDU icon
292
MDU Resources
MDU
$4.44B
– –
-302,495
Closed -$4.59M
MRK icon
293
Merck
MRK
$324B
– –
-139,682
Closed -$15.9M
MYE icon
294
Myers Industries
MYE
$1.18B
– –
-127,508
Closed -$1.76M
ACH
295
Accendra Health
ACH
$240M
– –
-333,843
Closed -$5.24M
OSK icon
296
Oshkosh
OSK
$9.67B
– –
-38,513
Closed -$3.86M
PHM icon
297
Pultegroup
PHM
$24.5B
– –
-1,475
Closed -$212K
PINE
298
Alpine Income Property Trust
PINE
$339M
– –
-45,270
Closed -$824K
PLYM
299
DELISTED
Plymouth Industrial REIT
PLYM
– –
-164,825
Closed -$3.73M
PRGO icon
300
Perrigo
PRGO
$1.4B
– –
-271,090
Closed -$7.11M
9 10 11
12
13

Similar funds

ST
Sabal Trust St. Petersburg, Florida $1.8B AUM 8.75% 1-Year Est. Return
UH
Unigestion Holding Geneva, Switzerland $1.7B AUM 9.06% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return

Foundry Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Foundry Partners held 309 positions worth $1.99B, down 1.5% from $2.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Foundry Partners's Q4 2024 filing shows 25 new, 122 increased, 118 reduced and 40 closed positions. Its largest new stake was Bristol-Myers Squibb: 406,683 shares worth $23M. The largest sale was GSK, an estimated $16M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Foundry Partners's largest Q4 2024 buy was Bristol-Myers Squibb: 406,683 shares worth $23M.
  • Foundry Partners added most to Walt Disney in Q4 2024, an estimated $8.81M increase.
  • Foundry Partners's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $11.1M.
  • Foundry Partners fully exited GSK in Q4 2024, selling an estimated $16M.
  • Foundry Partners's ten largest holdings make up 18% of its $1.99B portfolio in Q4 2024.
  • Foundry Partners opened 25 new positions and closed 40 in Q4 2024.
  • Foundry Partners's portfolio value fell 1.5% quarter-over-quarter to $1.99B.

Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.